SCHEMBL28239355

SCHEMBL28239355

CC(=O)CC1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.44
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
PDE8B O95263 1/20 0.42
ATM Q13315 2/20 0.41
OPRD1 P41143 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
FPR3 P25089 1/20 0.40
FPR2 P25090 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13337700 1.00 HSD17B10 (0.47) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL3156957 0.94 PDE8B (0.45) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL27426143 0.88 HSD17B10 (0.47) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL894504 0.88 HSD17B10 (0.50) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL115846 0.88 HSD17B10 (0.50) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL144831 0.88 HSD17B10 (0.50) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
Hydrochloric Acid SCHEMBL25198974 0.86 HSD17B10 (0.49) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL21946826 0.86 HSD17B10 (0.46) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL7352007 0.86 HSD17B10 (0.46) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR
SCHEMBL31436233 0.86 HSD17B10 (0.46) HSD17B10SMN1; SMN2NPC1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108391422-A Pyrrolobenzodiazepine antibody-drug conjugates and methods of use 豪夫迈·罗氏有限公司 2018-08-10 CN disclosed
CN-102427731-A Hepatitis c virus inhibitors ENANTA PHARM INC 2012-04-25 CN disclosed